This open-label pilot study (n=5) tested a single 25 mg dose of psilocybin with Acceptance and Commitment Therapy-based psychotherapy in adults with binge eating disorder and found the treatment was feasible and well tolerated, with no serious adverse events. Participants reported fewer binge eating episodes, along with improvements in depression, anxiety and psychological flexibility over 14 weeks.
- Published
- Journal
- Journal of Eating Disorders
- Authors
- Dallery, J., Miller, J. L., Boissoneault, J., Harvey, L., Ives, L., Knerr, A., Blaes, S., Ransom, M. N., Munson, M., Gilligan, J. P., Silverman, M. H., Guzzo, P. R., Loeser, B.